The complexity of obesity necessitates comprehensive treatment strategies that integrate immunomodulatory therapies with existing pharmacotherapies, such as metformin and GLP-1 receptor agonists, known for their efficacy in managing obesity and its metabolic consequences [124,125]. The gene discussed is GLP1R; the disease is obesity disorder.